Safety and Efficacy of Inhaled Human Insulin (Exubera) During Discontinuation and Readministration of Therapy in Adults with Type 2 Diabetes: A 3-Year Randomized Controlled Trial
Author:
Affiliation:
1. Dallas Diabetes and Endocrine Center, Dallas, Texas.
2. Pennington Biomedical Research Center, Baton Rouge, Louisiana.
3. Baylor University Medical Center, Dallas, Texas.
4. Pfizer Global Research and Development, New London, Connecticut.
Publisher
Mary Ann Liebert Inc
Subject
Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://www.liebertpub.com/doi/pdf/10.1089/dia.2009.0062
Reference29 articles.
1. Efficacy of Inhaled Insulin in Patients With Type 2 Diabetes not Controlled With Diet and Exercise
2. Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes
3. An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea
4. An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin
5. Long-term tolerability of inhaled human insulin (Exubera®) in patients with poorly controlled type 2 diabetes
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Celebrating a Century of Insulin Discovery: A Critical Appraisal of the Emerging Alternative Insulin Delivery Systems;Current Drug Delivery;2023-07
2. Mid‐childhood fat mass and airflow limitation at 15 years: The mediating role of insulin resistance and C‐reactive protein;Pediatric Allergy and Immunology;2022-12
3. Results of a 24-Week Trial of Technosphere Insulin Versus Insulin Aspart in Type 2 Diabetes;Endocrine Practice;2021-01
4. Advancements in the co-formulation of biologic therapeutics;Journal of Controlled Release;2020-11
5. Metabolic Dysfunction and Asthma: Current Perspectives;Journal of Asthma and Allergy;2020-07
Metabolic Dysfunction and Asthma: Current Perspectives
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3